SCM
DRUG

Superstring Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Superstring Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$971K Sell
13,311
-33,967
-72% -$2.73M 0.69% 29
2025
Q4 		$3.69M Sell
47,278
-6,672
-12% -$446K 1.98% 18
2025
Q3 		$3.27M Buy
+53,950
New +$2.09M 3.22% 14

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Superstring Capital Management's DRUG Position: Q1 2026 in Review

Superstring Capital Management reduced its Bright Minds Biosciences (DRUG) stake by 72% in Q1 2026, selling an estimated $2.73M and leaving 13,311 shares worth $971K. The position accounts for 0.69% of the portfolio, ranked #29.

Superstring Capital Management first reported a position in DRUG in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.69M in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Superstring Capital Management held 13,311 shares of Bright Minds Biosciences worth $971K as of Q1 2026.
  • Superstring Capital Management sold 33,967 Bright Minds Biosciences shares in Q1 2026, an estimated $2.73M.
  • Bright Minds Biosciences made up 0.69% of Superstring Capital Management's portfolio in Q1 2026, its #29 holding.
  • Superstring Capital Management first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Superstring Capital Management's Bright Minds Biosciences position peaked at $3.69M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Superstring Capital Management's 13F filing for Q1 2026, filed 14 May 2026.